Status:

COMPLETED

Type 2 Diabetes Mellitus Prevention Ukraine

Lead Sponsor:

Komisarenko Institute of Endocrinology and Metobolism

Conditions:

Impaired Fasting Glucose

Impaired Glucose Tolerance

Eligibility:

All Genders

18-79 years

Phase:

PHASE2

Brief Summary

Development, implementation and evaluation of the effectiveness of lifestyle recommendations for the prevention of type 2 diabetes in rural population of Ukraine

Detailed Description

An oral glucose tolerance test and anthropometric measurements were performed for 300 randomly selected rural residents of the Kyiv region of Ukraine. Persons from impaired glucose regulation category...

Eligibility Criteria

Inclusion

  • Persons with fasting blood glucose level \>=6.1 mmol/l; persons aged 18-79 who signed an informed consent for the study.

Exclusion

  • Known diabetes; acute infectious diseases; other serious diseases

Key Trial Info

Start Date :

February 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2021

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04283201

Start Date

February 20 2020

End Date

December 31 2021

Last Update

August 26 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

V.P.Komisarenko Institute of Endocrinology and Metabolism

Kyiv, Ukraine, 04114